In our study, we assessed 6 biomarkers (LAPTM4B, RANKL, OPG, YKL-40, VIT D, and SIRT1), LAPTM4B was first identified as a hepatocellular carcinoma-related gene in mammals (Liu et al., 2003). Here, LAPTM4B is linked to hepatocellular carcinoma.